Principles of rehabilitation and reactivation: Interstitial lung disease, sarcoidosis and rheumatoid disease with respiratory involvement

Respiration

Volumn 89, Issue 2, 2015, Pages 89-99

  Holland, Anne E ^a,b,c   Dowman, Leona M ^a,b,d   Hill, Catherine J ^b,d  

^a LA TROBE UNIVERSITY   (Australia)

^b Institute for Breathing and Sleep   (Australia)

^c Alfred Health ^*  (Australia)

^d AUSTIN HEALTH   (Australia)

Author keywords

Connective tissue diseases; Exercise; Interstitial lung diseases

Indexed keywords

OXYHEMOGLOBIN;

AEROBIC EXERCISE; ARTHRALGIA; CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONNECTIVE TISSUE DISEASE; DISEASE COURSE; DISEASE SEVERITY; DYSPNEA; ECHOCARDIOGRAPHY; EFFECT SIZE; FIBROSING ALVEOLITIS; HEART ARRHYTHMIA; HUMAN; INTERSTITIAL LUNG DISEASE; JOINT STIFFNESS; LUNG ARTERY PRESSURE; OXYGEN THERAPY; PATHOPHYSIOLOGY; PRESCRIPTION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; PULMONARY REHABILITATION; QUALITY OF LIFE; RESISTANCE TRAINING; REVIEW; RHEUMATIC DISEASE; SARCOIDOSIS; STANDARD; SUPRAVENTRICULAR PREMATURE BEAT; KINESIOTHERAPY; LUNG DISEASES, INTERSTITIAL; PATIENT SELECTION; RHEUMATIC DISEASES; SARCOIDOSIS, PULMONARY;

EXERCISE THERAPY; HUMANS; LUNG DISEASES, INTERSTITIAL; PATIENT SELECTION; RHEUMATIC DISEASES; SARCOIDOSIS, PULMONARY;

EID: 84921905968     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000370126     Document Type: Review

References (85)

1. Spruit MA, Pitta F, Garvey C, Zu Wallack RL, Roberts CM, Collins EG, Goldstein R, McNamara R, Surpas P, Atsuyoshi K, Lopez-Campos JL, Vogiatzis I, Williams JE, Lareau S, Brooks D, Troosters T, Singh SJ, Hartl S, Clini EM, Wouters EF: Differences in content and organisational aspects of pulmonary rehabilitation programmes. Eur Respir J 2014; 43: 1326-1337.
2. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King TE Jr, Kondoh Y, Myers J, Muller NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, Griss BS, Protzko SL, Schunemann HJ: An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidencebased guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183: 788-824.
3. The Diagnosis and Management of Suspected Idiopathic Pulmonary Fibrosis: NICE Clinical Guideline 163. London, National Institute for Health and Care Excellence, 2013.
4. Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, Hill K, Holland AE, Lareau SC, Man WD, Pitta F, Sewell L, Raskin J, Bourbeau J, Crouch R, Franssen FM, Casaburi R, Vercoulen JH, Vogiatzis I, Gosselink R, Clini EM, Effing TW, Maltais F, van der Palen J, Troosters T, Janssen DJ, Collins E, Garcia-Aymerich J, Brooks D, Fahy BF, Puhan MA, Hoogendoorn M, Garrod R, Schols AM, Carlin B, Benzo R, Meek P, Morgan M, Rutten-van Molken MP, Ries AL, Make B, Goldstein RS, Dowson CA, Brozek JL, Donner CF, Wouters EF: An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 2013; 188:e13-e64.
5. Poletti V, Ravaglia C, Buccioli M, Tantalocco P, Piciucchi S, Dubini A, Carloni A, Chilosi M, Tomassetti S: Idiopathic pulmonary fibrosis: diagnosis and prognostic evaluation. Respiration 2013; 86: 5-12.
6. Fischer A, du Bois R: Interstitial lung disease in connective tissue disorders. Lancet 2012; 380: 689-698.
7. Patterson KC, Strek ME: Pulmonary fibrosis in sarcoidosis. Clinical features and outcomes. Ann Am Thorac Soc 2013; 10: 362-370.
8. Lettieri CJ, Nathan SD, Barnett SD, Ahmad S, Shorr AF: Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 2006; 129: 746-752.
9. Nihtyanova SI, Schreiber BE, Ong VH, Rosenberg D, Moinzadeh P, Coghlan JG, Wells AU, Denton CP: Prediction of pulmonary complications and long-term survival in systemic sclerosis. Arthritis Rheumatol 2014; 66: 1625-1635.
10. Holland AE: Exercise limitation in interstitial lung disease-mechanisms, significance and therapeutic options. Chron Respir Dis 2010; 7: 101-111.
11. Eaton T, Young P, Milne D, Wells AU: Sixminute walk, maximal exercise tests: reproducibility in fibrotic interstitial pneumonia. Am J Respir Crit Care Med 2005; 171: 1150-1157.
12. Flaherty KR, Andrei AC, Murray S, Fraley C, Colby TV, Travis WD, Lama V, Kazerooni EA, Gross BH, Toews GB, Martinez FJ: Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test. Am J Respir Crit Care Med 2006; 174: 803-809.
13. Agusti AG, Roca J, Gea J, Wagner PD, Xaubet A, Rodriguez-Roisin R: Mechanisms of gasexchange impairment in idiopathic pulmonary fibrosis. Am Rev Respir Dis 1991; 143: 219-225.
14. Miki K, Maekura R, Hiraga T, Okuda Y, Okamoto T, Hirotani A, Ogura T: Impairments and prognostic factors for survival in patients with idiopathic pulmonary fibrosis. Respir Med 2003; 97: 482-490.
15. Lama VN, Flaherty KR, Toews GB, Colby TV, Travis WD, Long Q, Murray S, Kazerooni EA, Gross BH, Lynch JP 3rd, Martinez FJ: Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 2003; 168: 1084-1090.
16. Holland AE, Dowman L, Fiore J Jr, Brazzale D, Hill CJ, McDonald CF: Cardiorespiratory responses to 6-minute walk test in interstitial lung disease: not always a submaximal test. BMC Pulm Med 2014; 14: 136.
17. Risk C, Epler GR, Gaensler EA: Exercise alveolar-arterial oxygen pressure difference in interstitial lung disease. Chest 1984; 85: 69-74.
18. Agusti AG, Roca J, Rodriguez-Roisin R, Xaubet A, Agusti-Vidal A: Different patterns of gas exchange response to exercise in asbestosis and idiopathic pulmonary fibrosis. Eur Respir J 1988; 1: 510-516.
19. Sudduth CD, Strange C, Cook WR, Miller KS, Baumann M, Collop NA, Silver RM: Failure of the circulatory system limits exercise performance in patients with systemic sclerosis. Am J Med 1993; 95: 413-418.
20. Glaser S, Noga O, Koch B, Opitz CF, Schmidt B, Temmesfeld B, Dorr M, Ewert R, Schaper C: Impact of pulmonary hypertension on gas exchange and exercise capacity in patients with pulmonary fibrosis. Respir Med 2009; 103: 317-324.
21. Leuchte HH, Baumgartner RA, Nounou ME, Vogeser M, Neurohr C, Trautnitz M, Behr J: Brain natriuretic peptide is a prognostic parameter in chronic lung disease. Am J Respir Crit Care Med 2006; 173: 744-750.
22. Swigris JJ, Swick J, Wamboldt FS, Sprunger D, du Bois R, Fischer A, Cosgrove GP, Frankel SK, Fernandez-Perez ER, Kervitsky D, Brown KK: Heart rate recovery after 6-min walk test predicts survival in patients with idiopathic pulmonary fibrosis. Chest 2009; 136: 841-848.
23. Holland AE, Hill CJ, Glaspole I, Goh N, Dowman L, McDonald CF: Impaired chronotropic response to 6-min walk test and reduced survival in interstitial lung disease. Respir Med 2013; 107: 1066-1072.
24. Gibbons WJ, Levy RD, Nava S, Malcolm I, Marin JM, Tardif C, Magder S, Lisbona R, Cosio MG: Subclinical cardiac dysfunction in sarcoidosis. Chest 1991; 100: 44-50.
25. Mendoza L, Gogali A, Shrikrishna D, Cavada G, Kemp SV, Natanek SA, Jackson AS, Polkey MI, Wells AU, Hopkinson NS: Quadriceps strength and endurance in fibrotic idiopathic interstitial pneumonia. Respirology 2014; 19: 138-143.
26. Spruit MA, Thomeer MJ, Gosselink R, Troosters T, Kasran A, Debrock AJ, Demedts MG, Decramer M: Skeletal muscle weakness in patients with sarcoidosis and its relationship with exercise intolerance and reduced health status. Thorax 2005; 60: 32-38.
27. Marcellis RG, Lenssen AF, Elfferich MD, De Vries J, Kassim S, Foerster K, Drent M: Exercise capacity, muscle strength and fatigue in sarcoidosis. Eur Respir J 2011; 38: 628-634.
28. Madsen OR, Egsmose C, Hansen B, Sorensen OH: Soft tissue composition, quadriceps strength, bone quality and bone mass in rheumatoid arthritis. Clin Exp Rheumatol 1998; 16: 27-32.
29. Nishiyama O, Taniguchi H, Kondoh Y, Kimura T, Ogawa T, Watanabe F, Arizono S: Quadriceps weakness is related to exercise capacity in idiopathic pulmonary fibrosis. Chest 2005; 127: 2028-2033.
30. Watanabe F, Taniguchi H, Sakamoto K, Kondoh Y, Kimura T, Kataoka K, Ogawa T, Arizono S, Nishiyama O, Hasegawa Y: Quadriceps weakness contributes to exercise capacity in nonspecific interstitial pneumonia. Respir Med 2013; 107: 622-628.
31. Mengshoel AM, Jokstad K, Bjerkhoel F: Associations between walking time, quadriceps muscle strength and cardiovascular capacity in patients with rheumatoid arthritis and ankylosing spondylitis. Clin Rheumatol 2004; 23: 299-305.
32. Kozu R, Jenkins S, Senjyu H: Evaluation of activity limitation in patients with idiopathic pulmonary fibrosis grouped according to medical research council dyspnea grade. Arch Phys Med Rehab 2014; 95: 950-955.
33. Wallaert B, Monge E, Le Rouzic O, Wemeau-Stervinou L, Salleron J, Grosbois JM: Physical activity in daily life of patients with fibrotic idiopathic interstitial pneumonia. Chest 2013; 144: 1652-1658.
34. Kramer HR, Fontaine KR, Bathon JM, Giles JT: Muscle density in rheumatoid arthritis: associations with disease features and functional outcomes. Arthritis Rheum 2012; 64: 2438-2450.
35. Nessrine A, Zahra AF, Taoufik H: Musculoskeletal involvement in sarcoidosis. J Bras Pneumol 2014; 40: 175-182.
36. Marighela TF, Genaro Pde S, Pinheiro MM, Szejnfeld VL, Kayser C: Risk factors for body composition abnormalities in systemic sclerosis. Clin Rheumatol 2013; 32: 1037-1044.
37. Partovi S, Schulte AC, Aschwanden M, Staub D, Benz D, Imfeld S, Jacobi B, Broz P, Jager KA, Takes M, Huegli RW, Bilecen D, Walker UA: Impaired skeletal muscle microcirculation in systemic sclerosis. Arthritis Res Ther 2012; 14:R209.
38. King C, Nathan SD: Identification and treatment of comorbidities in idiopathic pulmonary fibrosis and other fibrotic lung diseases. Curr Opin Pulm Med 2013; 19: 466-473.
39. Nathan SD, Basavaraj A, Reichner C, Shlobin OA, Ahmad S, Kiernan J, Burton N, Barnett SD: Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis. Respir Med 2010; 104: 1035-1041.
40. Ryerson CJ, Hartman T, Elicker BM, Ley B, Lee JS, Abbritti M, Jones KD, King TE Jr, Ryu J, Collard HR: Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis. Chest 2013; 144: 234-240.
41. Holland AE, Fiore JF Jr, Bell EC, Goh N, Westall G, Symons K, Dowman L, Glaspole I: Dyspnoea and comorbidity contribute to anxiety and depression in interstitial lung disease. Respirology 2014; 19: 1215-1221.
42. Ryerson CJ, Arean PA, Berkeley J, Carrieri-Kohlman VL, Pantilat SZ, Landefeld CS, Collard HR: Depression is a common and chronic comorbidity in patients with interstitial lung disease. Respirology 2012; 17: 525-532.
43. Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, Cottin V, Flaherty KR, Hansell DM, Inoue Y, Kim DS, Kolb M, Nicholson AG, Noble PW, Selman M, Taniguchi H, Brun M, Le Maulf F, Girard M, Stowasser S, Schlenker-Herceg R, Disse B, Collard HR; INPULSIS Trial Investigators: Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 2014; 370: 2071-2082.
44. King TE Jr, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, Gorina E, Hopkins PM, Kardatzke D, Lancaster L, Lederer DJ, Nathan SD, Pereira CA, Sahn SA, Sussman R, Swigris JJ, Noble PW; ASCEND Study Group: A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med 2014; 370: 2083-2092.
45. Dowman L, Hill CJ, Holland AE: Pulmonary rehabilitation for interstitial lung disease. Cochrane Database Syst Rev 2014; 10:CD006322.
46. Lacasse Y, Goldstein R, Lasserson TJ, Martin S: Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006; 4:CD003793.
47. Holland AE, Hill CJ, Conron M, Munro P, McDonald CF: Small changes in six-minute walk distance are important in diffuse parenchymal lung disease. Respir Med 2009; 103: 1430-1435.
48. Naji NA, Connor MC, Donnelly SC, Mc-Donnell TJ: Effectiveness of pulmonary rehabilitation in restrictive lung disease. J Cardiopulm Rehabil 2006; 26: 237-243.
49. Ferreira A, Garvey C, Connors GL, Hilling L, Rigler J, Farrell S, Cayou C, Shariat C, Collard HR: Pulmonary rehabilitation in interstitial lung disease: benefits and predictors of response. Chest 2009; 135: 442-447.
50. Ryerson CJ, Cayou C, Topp F, Hilling L, Camp PG, Wilcox PG, Khalil N, Collard HR, Garvey C: Pulmonary rehabilitation improves long-term outcomes in interstitial lung disease: a prospective cohort study. Respir Med 2014; 108: 203-210.
51. Swigris JJ, Fairclough DL, Morrison M, Make B, Kozora E, Brown KK, Wamboldt FS: Beneficial effects of pulmonary rehabilitation in idiopathic pulmonary fibrosis. Respir Care 2011; 56: 783-789.
52. Maltais F, Decramer M, Casaburi R, Barreiro E, Burelle Y, Debigare R, Dekhuijzen PN, Franssen F, Gayan-Ramirez G, Gea J, Gosker HR, Gosselink R, Hayot M, Hussain SN, Janssens W, Polkey MI, Roca J, Saey D, Schols AM, Spruit MA, Steiner M, Taivassalo T, Troosters T, Vogiatzis I, Wagner PD; ATS/ERS Ad Hoc Committee on Limb Muscle Dysfunction in COPD: An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2014; 189: e15-e62.
53. Salhi B, Troosters T, Behaegel M, Joos G, Derom E: Effects of pulmonary rehabilitation in patients with restrictive lung diseases. Chest 2010; 137: 273-279.
54. Gaunaurd IA, Gomez-Marin OW, Ramos CF, Sol CM, Cohen MI, Cahalin LP, Cardenas DD, Jackson RM: Physical activity and quality of life improvements of patients with idiopathic pulmonary fibrosis completing a pulmonary rehabilitation program. Respir Care 2014; 59: 1872-1879.
55. Holland AE, Hill CJ, Conron M, Munro P, McDonald CF: Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease. Thorax 2008; 63: 549-554.
56. Holland AE, Hill CJ, Glaspole I, Goh N, Mc-Donald CF: Predictors of benefit following pulmonary rehabilitation for interstitial lung disease. Respir Med 2012; 106: 429-435.
57. Kozu R, Jenkins S, Senjyu H: Effect of disability level on response to pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Respirology 2011; 16: 1196-1202.
58. Nishiyama O, Kondoh Y, Kimura T, Kato K, Kataoka K, Ogawa T, Watanabe F, Arizono S, Nishimura K, Taniguchi H: Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Respirology 2008; 13: 394-399.
59. Jackson RM, Gomez-Marin OW, Ramos CF, Sol CM, Cohen MI, Gaunaurd IA, Cahalin LP, Cardenas DD: Exercise limitation in IPF patients: a randomized trial of pulmonary rehabilitation. Lung 2014; 192: 367-376.
60. Baradzina HL, Ponachevnaya NV: Pulmonary rehabilitation programme in sarcoidosis (abstract). Eur Respir J 2005; 26(suppl 49): 333S.
61. Mejia RA, Sansores RH, Perez-Padilla R, Mahler DA: Effects of exercise training on 'quality of life' in patients with interstitial lung diseases (abstract). Eur Respir J 2000; 16: 330S.
62. Menon B, Vijayan VK, Bansal V, Prajapat B: Effect of pulmonary rehabilitation on gas exchange, muscle cross section area and functional parameters in interstitial lung disease (abstract). Eur Respir J 2011; 38: 878S.
63. Perez Bogerd S, Wuyts W, et al: Preliminary results of pulmonary rehabilitation in interstitial lung diseases: a randomised controlled trial (abstract). Eur Respir J 2011; 38: 259S.
64. Vainshelboim B, Oliveira L, Yohoshua L, Weis I, Fox B, Kramer M: The effect of pulmonary rehabilitation on exercise tolerance, pulmonary function, dyspnea and quality of life in patients with idiopathic pulmonary fibrosis (abstract). Eur Respir J 2013; 187: A1832.
65. Bolton CE, Bevan-Smith EF, Blakey JD, Crowe P, Elkin SL, Garrod R, Greening NJ, Heslop K, Hull JH, Man WD, Morgan MD, Proud D, Roberts CM, Sewell L, Singh SJ, Walker PP, Walmsley S; British Thoracic Society Pulmonary Rehabilitation Guideline Development G; British Thoracic Society Standards of Care C: British Thoracic Society guideline on pulmonary rehabilitation in adults. Thorax 2013; 68(suppl 2):ii1-ii30.
66. Jenkins S, Cecins N: Six-minute walk test: observed adverse events and oxygen desaturation in a large cohort of patients with chronic lung disease. Intern Med J 2011; 41: 416-422.
67. Park JH, Jegal Y, Shim TS, Lim CM, Lee SD, Koh Y, Kim WS, Kim WD, du Bois R, Do KH, Kim DS: Hypoxemia and arrhythmia during daily activities and six-minute walk test in fibrotic interstitial lung diseases. J Korean Med Sci 2011; 26: 372-378.
68. Pouwels-Fry S, Pouwels S, Fournier C, Duchemin A, Tillie-Leblond I, Le Tourneau T, Wallaert B: Effects of oxygen on exercise-induced increase of pulmonary arterial pressure in idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis 2008; 25: 133-139.
69. Wilsher M, Good N, Hopkins R, Young P, Milne D, Gibson A, Suppiah R, Ly J, Doughty R, Dalbeth N: The six-minute walk test using forehead oximetry is reliable in the assessment of scleroderma lung disease. Respirology 2012; 17: 647-652.
70. Emtner M, Porszasz J, Burns M, Somfay A, Casaburi R: Benefits of supplemental oxygen in exercise training in nonhypoxemic chronic obstructive pulmonary disease patients. Am J Respir Crit Care Med 2003; 168: 1034-1042.
71. Hill K, Holland AE: Strategies to enhance the benefits of exercise training in the respiratory patient. Clin Chest Med 2014;35:323-336.
72. Beauchamp MK, Nonoyama M, Goldstein RS, Hill K, Dolmage TE, Mathur S, Brooks D: Interval versus continuous training in individuals with chronic obstructive pulmonary disease-A systematic review. Thorax 2010; 65: 157-164.
73. Vogiatzis I, Nanas S, Roussos C: Interval training as an alternative modality to continuous exercise in patients with COPD. Eur Respir J 2002; 20: 12-19.
74. Vogiatzis I, Terzis G, Nanas S, Stratakos G, Simoes DC, Georgiadou O, Zakynthinos S, Roussos C: Skeletal muscle adaptations to interval training in patients with advanced COPD. Chest 2005; 128: 3838-3845.
75. Arnardottir RH, Boman G, Larsson K, Hedenstrom H, Emtner M: Interval training compared with continuous training in patients with COPD. Respir Med 2007; 101: 1196-1204.
76. Mador MJ, Krawza M, Alhajhusian A, Khan AI, Shaffer M, Kufel TJ: Interval training versus continuous training in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehab Prev 2009; 29: 126-132.
77. Dolmage TE, Goldstein RS: Response to onelegged cycling in patients with COPD. Chest 2006; 129: 325-332.
78. Dolmage TE, Goldstein RS: Effects of onelegged exercise training of patients with COPD. Chest 2008; 133: 370-376.
79. Bjorgen S, Hoff J, Husby VS, Hoydal MA, Tjonna AE, Steinshamn S, Richardson RS, Helgerud J: Aerobic high intensity one and two legs interval cycling in chronic obstructive pulmonary disease: the sum of the parts is greater than the whole. Eur J Appl Physiol 2009; 106: 501-507.
80. Zanotti E, Felicetti G, Maini M, Fracchia C: Peripheral muscle strength training in bedbound patients with COPD receiving mechanical ventilation: effect of electrical stimulation. Chest 2003; 124: 292-296.
81. Vivodtzev I, Pepin JL, Vottero G, Mayer V, Porsin B, Levy P, Wuyam B: Improvement in quadriceps strength and dyspnea in daily tasks after 1 month of electrical stimulation in severely deconditioned and malnourished COPD. Chest 2006; 129: 1540-1548.
82. McNamara RJ, McKeough ZJ, McKenzie DK, Alison JA: Water-based exercise in COPD with physical comorbidities: a randomised controlled trial. Eur Respir J 2013; 41: 1284-1291.
83. Schoenheit G, Becattelli I, Cohen AH: Living with idiopathic pulmonary fibrosis: an indepth qualitative survey of European patients. Chron Respir Dis 2011; 8: 225-231.
84. Lee AS, Mira-Avendano I, Ryu JH, Daniels CE: The burden of idiopathic pulmonary fibrosis: an unmet public health need. Respir Med 2014; 108: 955-967.
85. Burge AT, Lee A, Nicholes M, Purcell S, Miller B, Norris N, McArdle S, Sandilands S, Holland AE: Advance care planning education in pulmonary rehabilitation: a qualitative study exploring participant perspectives. Palliat Med 2013; 27: 508-515